Prostaglandin-timolol fixed combinations efficacy: Myth or reality?

European Journal of Ophthalmology

Volumn 22, Issue 1, 2011, Pages 1-4

  Konstas, Anastasios G P ^a   Haidich, Anna Bettina ^b   Rossetti, Luca ^c   Webers, Carroll ^d  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF MILAN   (Italy)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BIMATOPROST PLUS TIMOLOL; LATANOPROST PLUS TIMOLOL; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN PLUS TIMOLOL; TIMOLOL; TIMOLOL PLUS TRAVOPROST; UNCLASSIFIED DRUG;

BIOEQUIVALENCE; BLINDNESS; CONJUNCTIVAL HYPEREMIA; DOSAGE SCHEDULE COMPARISON; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EDITORIAL; EVENING DOSAGE; EVIDENCE BASED MEDICINE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LONG TERM CARE; MONOTHERAPY; MORNING DOSAGE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AMIDES; ANTIHYPERTENSIVE AGENTS; CLOPROSTENOL; HUMANS; INTRAOCULAR PRESSURE; PROSTAGLANDINS F, SYNTHETIC; TIMOLOL;

EID: 81855166778     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000077     Document Type: Editorial

References (30)

1. Konstas AGP, Mikropoulos D, Stewart WC. Fixed combination therapy in glaucoma. In: Shaarawy T, Hitchings R, Sherwood M, Crowston J, eds. Glaucoma. Philadelphia: Elsevier, 2009; 565-75.
2. Olthoff CM, Schouten JSAG, Vandeborne B, Webers C. Noncom-pliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension. Ophthalmology 2005; 112: 953-61.
3. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120: 713-9.
4. Konstas AGP, Boboridis K, Stewart WC, et al. 24hour intraocular pressure short-term control with the latanoprost/timolol maleate fixed combination versus latanoprost, both dosed once each evening, in primary open-angle glaucoma patients. Arch Ophthalmol 2005; 123: 898-902.
5. Konstas AGP, Mikropoulos D, Haidich AB, Ntampos KS, Stewart WC. Twenty-four-hour intraocular pressure control with the tra-voprost/timolol maleate fixed combination compared with travo-prost when both are dosed in the evening in primary open-angle glaucoma. Br J Ophthalmol 2009; 93: 481-5.
6. Konstas AGP, Hollo G, Mikropoulos DG, et al. Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma. Br J Ophthalmol 2010; 94: 209-13.
7. Pearson K. Report on certain enteric fever inoculation statistics. BMJ 1904; 3: 1243-6.
8. Glass G V. Primary, secondary and meta-analysis of research. Educ Res 1976; 5: 3-8.
9. Hennekens CH, DeMets DL, Bairey Merz CN, Borzak SL, Borer JS. Doing more good than harm: the need for a cease fire. Am J Med 2009; 122: 315-6.
10. Naylor CD. Meta-analysis and the meta-epidemiology of clinical research. BMJ 1997; 315: 617-9.
11. Bailar JC. The promise and problems of meta-analysis [editorial]. N Engl J Med 1997; 337: 559-61.
12. Meta-analysis under scrutiny [editorial]. Lancet 1997; 350: 675.
13. French SD, McDonald S, McKenzie JE, Green SE. Investing in updating: how do conclusions change when Cochrane systematic reviews are updated? BMC Med Res Methodol 2005; 5: 33.
14. Moher D, Tsertsvadze A, Tricco AC, et al. When and how to update systematic reviews. Cochrane Database Syst Rev 2008; MR000023.
15. Tasina E, Haidich AB, Kokkali S, Arvanitidou M. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. Lancet Infect Dis 2011; Jul: 22.
16. Ioannidis JPA, Karassa FB. The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence. BMJ 2010; 341: c4875.
17. Webers CAB, Beckers HJM, Zeegers M P, Nuijts RMMA, Hen-drikse F, Schouten JSAG. The intraocular pressure-lowering effect of prostaglandin analogs combined with topical β-blocker therapy: a systematic review and meta-analysis. Ophthalmology 2010; 117: 2067-74.
18. Webers CAB, van der-Valk R, Schouten JSAG, Zeegers M P, Prins MH, Hendrikse F. Intraocular pressure-lowering effect of adding dorzolamide or latanoprost to timolol: a meta-analysis of randomized clinical trials. Ophthalmology 2007; 114: 40-6.
19. van der Valk R, Webers CAB, Schouten JSAG, Zeegers M P, Hendrikse F, Prins MH. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 2005; 112: 1177-85.
20. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21: 2313-24.
21. van der Valk R, Webers CAB, Lumley T, Hendrikse F, Prins MH, Schouten JSAG. A network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressure. J Clin Epidemiol 2009; 62: 1279-83.
22. Baker WL, White MC, Cappelleri JC, Kluger J, Coleman CI, Health Outcomes, Policy, and Economics (HOPE) Collaborative Group. Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract 2009; 63: 1426-34.
23. Centofanti M, Oddone F, Gandolfi S, et al. Comparison of travo-prost and bimatoprost plus timolol fixed combinations in open angle glaucoma patients previously treated with latanoprost plus timolol fixed combination. Am J Ophthalmol 2010; 150: 575-80.
24. NICE Clinical Guideline 85. Glaucoma: Diagnosis and Management of Chronic Open Angle Glaucoma and Ocular Hypertension: Appendices A-G. Available at: http://www.nice.org.uk/nicemedia/ live/12145/43888/43888.pdf. Accessed September 30, 2011.
25. Vinuesa-Silva JM, Vinuesa-Silva I, Pinazo-Durn MD, Soto-Alvarez J, Delgado-Ortega L, DÌaz-Cerezo S. Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials. Arch Soc Esp Oftalmol 2009; 84: 199-207.
26. Cox JA, Mollan S P, Bankart J, Robinson R. Efficacy of antiglau-coma fixed combination therapy versus unfixed components in reducing intraocular pressure: a systematic review. Br J Oph-thalmol 2008; 92: 729-34.
27. Stewart WC, Konstas AGP, Nelson LA, Kruft B. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Ophthalmology 2008; 115: 1117-22.
28. Pfeiffer N. A comparison of the fixed combination of latanoprost and timolol with its individual components. Graefes Arch Clin Exp Ophthalmol 2002; 240: 893-9.
29. Higginbotham EJ, Feldman R, Stiles M, Dubiner H. Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial. Arch Ophthalmol 2002; 120: 915-22.
30. Alm A, Stjernschantz J. The Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol. Ophthalmology 1995; 102: 1743-52.